Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Long-Term Deferred Tax (2016 - 2025)

Iradimed (IRMD) has disclosed Long-Term Deferred Tax for 12 consecutive years, with $94000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 96.67% to $94000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94000.0 through Dec 2025, down 96.67% year-over-year, with the annual reading at $94000.0 for FY2025, 96.67% down from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $94000.0 at Iradimed, down from $2.4 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $2.8 million in Q4 2024, with the low at $94000.0 in Q4 2025.
  • Average Long-Term Deferred Tax over 5 years is $1.5 million, with a median of $1.4 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax soared 202.88% in 2023, then tumbled 96.67% in 2025.
  • Over 5 years, Long-Term Deferred Tax stood at $765096.0 in 2021, then decreased by 8.39% to $700867.0 in 2022, then skyrocketed by 202.88% to $2.1 million in 2023, then skyrocketed by 32.84% to $2.8 million in 2024, then crashed by 96.67% to $94000.0 in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $94000.0, $2.4 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.